The Vanguard Group 13D and 13G filings for Amneal Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-30 1:56 pm Purchase | 2025-03-31 | 13G | Amneal Pharmaceuticals, Inc. AMRX | The Vanguard Group | 15,762,727 5.020% | 2,120,340 (+15.54%) | Filing |
| 2024-02-13 4:58 pm Purchase | 2023-12-29 | 13G | Amneal Pharmaceuticals, Inc. AMRX | The Vanguard Group | 13,642,387 4.450% | 594,319 (+4.55%) | Filing |
| 2023-02-09 11:07 am Purchase | 2022-12-30 | 13G | Amneal Pharmaceuticals, Inc. AMRX | The Vanguard Group | 13,048,068 8.610% | 1,473,173 (+12.73%) | Filing |
| 2022-02-09 3:24 pm Purchase | 2021-12-31 | 13G | Amneal Pharmaceuticals, Inc. AMRX | The Vanguard Group | 11,574,895 7.750% | 592,064 (+5.39%) | Filing |
| 2021-02-10 10:30 am Purchase | 2020-12-31 | 13G | Amneal Pharmaceuticals, Inc. AMRX | The Vanguard Group | 10,982,831 7.440% | 797,756 (+7.83%) | Filing |